Celltrion
068270.KS
#723
Rank
S$35.16 B
Marketcap
$161.54
Share price
0.23%
Change (1 day)
-10.31%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Earnings for Celltrion (068270.KS)

Earnings in 2024 (TTM): S$0.62 Billion

According to Celltrion 's latest financial reports the company's current earnings are S$2.58 Billion. a decrease over its 2023 earnings that were of S$0.68 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Celltrion from 2008 to 2024

Annual earnings

Year Earnings Change
2024 S$0.62 B-8.8%
2023 S$0.68 B6.8%
2022 S$0.64 B-21.85%
2021 S$0.82 B10.25%
2020 S$0.74 B65.16%
2019 S$0.45 B16.64%
2018 S$0.38 B-33.89%
2017 S$0.58 B106.53%
2016 S$0.28 B25.57%
2015 S$0.22 B-6.54%
2014 S$0.24 B47.36%
2013 S$0.16 B-33.63%
2012 S$0.24 B
2010 S$0.12 B72.84%
2009 S$74.36 M260.54%
2008 S$20.62 M